Beam Therapeutics Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2020 to Q3 2024
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Beam Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q3 2024.
- Beam Therapeutics Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 82.4M shares, a 4.28% increase year-over-year.
- Beam Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 77.2M shares, a 10.2% increase from 2022.
- Beam Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 70M shares, a 9.01% increase from 2021.
- Beam Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 64.2M shares, a 37.4% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)